Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rosetta Genomics Ltd (NASDAQ:ROSG)

1.63
Delayed Data
As of Aug 22
 -0.02 / -1.21%
Today’s Change
1.40
Today|||52-Week Range
13.20
-67.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues2.6M2.4M2.2M2.0M
 
 
 
 
 
Cost of Goods Sold1.7M2.0M1.8M2.0M
 
 
 
 
 
 
Operating ExpensesGross Income945.0K423.0K410.0K17.0K
 
 
 
 
 
General Expenses5.0M3.8M4.4M4.3M
 
 
 
 
 
Research And Development842.0K618.0K879.0K818.0K
 
 
 
 
 
Total Operating Expenses6.6M5.8M6.1M6.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.0M-3.4M-3.9M-4.3M
 
 
 
 
 
Interest Expense On Debt0.00--16.0K563.0K
 
 
 
Other Expenses-24.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.0M-3.4M-4.0M-4.9M
 
 
 
 
 
Income Taxes-6.0K-6.0K-10.0K-56.0K
 
 
 
 
 
Net Income-4.0M-3.4M-4.0M-4.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.7M1.7M1.7M1.8M
 
 
 
 
 
Shares To Calculate EPS Diluted1.7M1.7M1.7M1.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.40-$1.92-$2.28--
 
 
 
 
EPS Diluted-$2.40-$1.92-$2.28-$2.76